4.5 Article

Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism

Journal

JOURNAL OF DIABETES
Volume 6, Issue 3, Pages 212-220

Publisher

WILEY
DOI: 10.1111/1753-0407.12081

Keywords

fatty acid desaturation; gene knockout mice; liver X receptor; SCD1; SREBP1c; X; SCD1; SREBP1c

Funding

  1. Ministry of Science and Technology [2010CB517504, 2011ZX09102]
  2. Natural Science Foundation [81121061/81270275/81030003, 81200511]
  3. Swedish Research Council
  4. Robert A. Welch Foundation [E-0004]

Ask authors/readers for more resources

BackgroundLiver X receptors (LXRs) including LXR and LXR are members of the nuclear hormone receptor superfamily of ligand activated transcription factors, which serve as lipid sensors to regulate expression of genes controlling many aspects of cholesterol and fatty acid metabolism. The liver is the central organ in controlling lipid metabolism. In the present study, we aimed at elucidating the role of LXR activation in hepatic fatty acid homeostasis. MethodsWe treated C57BL/6 mice with a synthetic non-selective LXR agonist TO901317. Fatty acid profile of lipid esters in the livers was analyzed by gas-liquid chromatography. Real-time polymerase chain reaction (PCR) and western blot were used to determine the expression of SREBP1c and SCD1 in TO901317-treated livers and HepG2 cells. ResultsOral administration of TO901317 resulted in increased fatty acid desaturation in the liver, with concomitant increase in hepatic stearoyl CoA desaturase-1 (SCD1) expression. TO901317-induced SCD1 expression was observed in LXR-/- mice, but not in LXR-/- mice. Furthermore, TO901317 significantly increased expression of sterol regulatory element-binding protein 1c (SREBP1c), the deficiency of which almost completely abolished the induction of SCD1 by TO901317. This drug induced both SREBP1c and SCD1 expression in HepG2 cells. Overexpression of SREBP1c resulted in a significant increase in SCD1 promoter activity and expression. ConclusionsTaken together, the present studies demonstrate that pan-LXR activation increases hepatic fatty acid desaturation via the induction of SCD1 expression in an LXR-dependent and SREBP1c-mediated manner. ?? ???X??(liver X receptors,LXRs)??LXR?LXR????????????,????????????,????LXR??????????,??????????????????????????????????????,??????LXR??????????????? ????????LXR???????TO901317??C57BL/6?????????????????????????????PCR????????????TO901317?????????HepG2??SREBP1c?SCD1???? ????TO901317???????????????,???????A????1(stearoyl CoA desaturase-1,SCD1)??????????LXR-/-??,TO901317??????SCD1???,??LXR-/-?????????????,?????,TO901317??SCD1?????????????????-1c(sterol regulatory element-binding protein1c,SREBP1c)?????,???SREBP1c-/-??TO901317??????SCD1????????HepG2??,TO901317????SREBP1c?SCD1???;SREBP1c??????SCD1?????????????? ???????LXR??????????????????????SCD1??????,?????LXR??SREBP1c???

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse liver

Bing Wang, Haibo Zhang, Zhilin Luan, Hu Xu, Yuanyi Wei, Xuejia Zhao, Miaomiao Xing, Xiaoxiao Huo, Jiayang Zhang, Wen Su, Youfei Guan, Xiaoyan Zhang

EXPERIMENTAL CELL RESEARCH (2020)

Article Endocrinology & Metabolism

Maternal and paternal histories differentially influence risks for diabetes, insulin secretion and insulin resistance in a Chinese population

Xiaomu Kong, Zhaojun Yang, Bo Zhang, Xiaoping Chen, Liping Yu, Haiqing Zhu, Xiaoyan Xing, Wenying Yang

Summary: Maternal and paternal history of diabetes have differential effects on the risks for diabetes, insulin secretion, and resistance in the Chinese population, suggesting they play a role in the pathogenesis of diabetes through distinct mechanisms.

JOURNAL OF DIABETES INVESTIGATION (2021)

Article Medicine, Research & Experimental

Endothelial cell prostaglandin E2 receptor EP4 is essential for blood pressure homeostasis

Hu Xu, Bingying Fang, Shengnan Du, Sailun Wang, Qingwei Li, Xiao Jia, Chengzhen Bao, Lan Ye, Xue Sui, Lei Qian, Zhilin Luan, Guangrui Yang, Feng Zheng, Nanping Wang, Lihong Chen, Xiaoyan Zhang, Youfei Guan

JCI INSIGHT (2020)

Article Biochemistry & Molecular Biology

Pregnane X receptor (PXR) protects against cisplatin-induced acute kidney injury in mice

Zhilin Luan, Yuanyi Wei, Xiaoxiao Huo, Xiaowan Sun, Cong Zhang, Wenhua Ming, Zhaokang Luo, Chunxiu Du, Yaqing Li, Hu Xu, Heyuan Lu, Feng Zheng, Youfei Guan, Xiaoyan Zhang

Summary: Activation of PXR significantly attenuates cisplatin-induced nephrotoxicity in mice by regulating multiple crucial signaling pathways, especially the PI3K/AKT pathway. In vitro studies suggest that PXR protects against cisplatin-induced apoptosis of proximal tubule cells in a PI3K-dependent manner. These results indicate that PXR activation may serve as a novel protective target for cisplatin-induced nephrotoxicity.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Article Immunology

MHC class II in renal tubules plays an essential role in renal fibrosis

Yunfeng Zhou, Zhaokang Luo, Chenghui Liao, Rong Cao, Zain Hussain, Jie Wang, Yeting Zhou, Tie Chen, Jie Sun, Zhong Huang, Baohua Liu, Xiaoyan Zhang, Youfei Guan, Tuo Deng

Summary: The study found that MHCII molecules are upregulated in proximal tubules in renal fibrosis models, promoting the proliferation of CD4(+) T cells. Ablation of H2-Ab1 significantly reduced renal fibrosis, and there was a correlation between the increase in CD4(+) T cells and MHCII expression in the kidneys.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Correction Biochemistry & Molecular Biology

Pregnane X receptor (PXR) protects against cisplatin-induced acute kidney injury in mice (vol 1867, 165996, 2021)

Zhilin Luan, Yuanyi Wei, Xiaoxiao Huo, Xiaowan Sun, Cong Zhang, Wenhua Ming, Zhaokang Luo, Chunxiu Du, Yaqing Li, Hu Xu, Heyuan Lu, Feng Zheng, Youfei Guan, Xiaoyan Zhang

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2022)

Review Biochemistry & Molecular Biology

HSD17B13: A Potential Therapeutic Target for NAFLD

Hai-bo Zhang, Wen Su, Hu Xu, Xiao-yan Zhang, You-fei Guan

Summary: Nonalcoholic fatty liver disease (NAFLD) is closely related to chronic liver disease, and research has shown that lipid droplet-associated proteins play an important role in its development, particularly HSD17B13. This protein has been found to be strongly associated with the development and progression of NAFLD/NASH, making it a potential therapeutic target.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Article Medical Laboratory Technology

Rapid detection of the irinotecan-related UGT1A128 polymorphism by asymmetric PCR melting curve analysis using one fluorescent probe

Xiaomu Kong, Ye Xu, Peng Gao, Yi Liu, Xuran Wang, Meimei Zhao, Yongwei Jiang, Hui Yang, Yongtong Cao, Liang Ma

Summary: A new method using PCR melting curve analysis with one fluorescent probe was developed to identify UGT1A1 (TA)(n) polymorphism. The application of this method in 64 patients showed accurate, reliable, rapid, simple, and low-cost detection of UGT1A1 (TA)(n) polymorphism.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)

Review Immunology

CD4+ T cell activation and inflammation in NASH-related fibrosis

Yunfeng Zhou, Haibo Zhang, Yao Yao, Xiaoyan Zhang, Youfei Guan, Feng Zheng

Summary: Liver fibrosis is a life-threatening disease worldwide, with nonalcoholic fatty liver disease (NAFLD) being a major cause, and immune response and inflammation playing important roles in the development and progression of NASH.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

PPARβ/δ Augments IL-1β-Induced COX-2 Expression and PGE2 Biosynthesis in Human Mesangial Cells via the Activation of SIRT1

Yaqing Li, Rong Cao, Tingting Gu, Cong Cao, Tingyue Chen, Youfei Guan, Xiaoyan Zhang

Summary: This study revealed that PPAR beta/delta enhances IL-1 beta-induced COX-2 expression and PGE2 production in hMCs via the SIRT1 pathway, providing further insights into the role of PPAR beta/delta in regulating renal inflammatory responses.

METABOLITES (2022)

Article Chemistry, Analytical

Fast and Sensitive Detection of SARS-CoV-2 Nucleic Acid Using a Rapid Detection System Free of RNA Extraction

Liang Ma, Yanyan Fan, Xiaomu Kong, Yongwei Jiang, Hong Huang, Meimei Zhao, Yi Liu, Peng Gao, Yong Cui, Yongtong Cao

Summary: This study established and evaluated the analytical and clinical performance of the Flash20 SARS-CoV-2 nucleic acid rapid detection system without the need for RNA extraction. The system showed high sensitivity and specificity in detecting the virus, which can contribute to early infection control and disease management.

INTERNATIONAL JOURNAL OF ANALYTICAL CHEMISTRY (2023)

Article Medical Laboratory Technology

Role of HLA class I and II alleles in susceptibility to ankylosing spondylitis in Chinese Han

Yongwei Jiang, Qian Liu, Xiaomu Kong, Meimei Zhao, Yi Liu, Peng Gao, Guoxiong Deng, Yongtong Cao, Liang Ma

Summary: In addition to HLA-B*27, other HLA class I and II alleles also contribute to the predisposition and characteristics of ankylosing spondylitis among Chinese Han patients. HLA-B*27-positive patients exhibit symptoms of AS at an earlier age. Certain alleles of HLA-I and HLA-II affect the age of onset of ankylosing spondylitis in the HLA-B*27(-) group.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2023)

Review Biochemistry & Molecular Biology

Role of FXR in Renal Physiology and Kidney Diseases

Yanlin Guo, Guixiang Xie, Xiaoyan Zhang

Summary: Farnesoid X receptor, also known as the bile acid receptor, is highly expressed in the liver, small intestine, kidney and adrenal gland. It regulates bile acid, glucose and lipid homeostasis by controlling the transcription of target genes, and participates in inflammatory, immune and fibrotic processes. In the kidney, FXR plays a crucial role in renal water reabsorption and is believed to have protective effects in acute kidney disease and chronic kidney disease, specifically diabetic kidney disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

The Emerging Therapeutic Role of Prostaglandin E2 Signaling in Pulmonary Hypertension

Lan Ye, Bing Wang, Hu Xu, Xiaoyan Zhang

Summary: Mild-to-moderate pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary disease (COPD) characterized by narrowing and thickening of the pulmonary arteries. The pathogenesis of PH in COPD is complex and involves chronic inflammation, hypoxia, and oxidative stress. Prostaglandin E2 (PGE2) and its receptors have been found to play an important role in regulating pulmonary vascular homeostasis and remodeling.

METABOLITES (2023)

Article Physiology

A naturally occurring FXR agonist, alisol B 23-acetate, protects against renal ischemia-reperfusion injury

Zhi-Lin Luan, Wen-Hua Ming, Xiao-Wan Sun, Cong Zhang, Yang Zhou, Feng Zheng, Yong-Liang Yang, You-Fei Guan, Xiao-Yan Zhang

Summary: This study identified alisol B 23-acetate (ABA) as a natural agonist of farnesoid X receptor (FXR) from Alismatis rhizoma, a traditional Chinese medicine, which exerts renoprotective effects against ischemic acute kidney injury (AKI) in an FXR-dependent manner. ABA showed potential as a novel therapeutic agent for AKI treatment in the future by improving renal function, reducing renal tubular apoptosis, ameliorating oxidative stress, and suppressing inflammatory factor expression.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2021)

No Data Available